Wang J Y, Hotta T, Murate T, Inoue C, Saito H, Ikeda Y, Ogawa H, Saito A
Rinsho Ketsueki. 1989 Jul;30(7):975-9.
We investigated the inhibitory effect of autologous sera on erythroid colony formation (CFU-E) of bone marrow cells from patients with chronic renal disease and the clinical effect of recombinant erythropoietin. Colonies formed in cultures using autologous serum (AS) decreased in 15 among 30 cases as compared with those using fetal calf serum (FCS). This inhibitory effect of autologous sera was diminished by treatment with activated charcoal in all these cases. The degree of hemoglobin increase after administration of recombinant erythropoietin appeared to correlate with the intensity of inhibitory activity of AS. These data indicate the clinical significance of the inhibitor(s) of erythropoiesis in uremic sera and suggest that the clinical effects of erythropoietin in this disease are further improved if the inhibitor(s) can be effectively removed.
我们研究了自体血清对慢性肾病患者骨髓细胞红系集落形成(CFU-E)的抑制作用以及重组促红细胞生成素的临床效果。与使用胎牛血清(FCS)培养相比,30例患者中有15例使用自体血清(AS)培养形成的集落减少。在所有这些病例中,用活性炭处理可减轻自体血清的这种抑制作用。给予重组促红细胞生成素后血红蛋白增加的程度似乎与AS的抑制活性强度相关。这些数据表明尿毒症血清中促红细胞生成抑制剂的临床意义,并提示如果能有效去除抑制剂,促红细胞生成素在该疾病中的临床效果将得到进一步改善。